Attached files
| file | filename |
|---|---|
| EX-99.1 - EXHIBIT 99.1 - MEDCO HEALTH SOLUTIONS INC | c00987exv99w1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to
Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 13, 2010
MEDCO HEALTH SOLUTIONS, INC.
(Exact name of registrant as specified in its charter)
| Delaware | 1-31312 | 22-3461740 | ||
| (State or other Jurisdiction of Incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
| 100 Parsons Pond Drive, Franklin Lakes, NJ |
07417 | |
| (Address of Principal Executive Offices) | (Zip Code) |
Registrant’s telephone number, including area code: 201-269-3400
| (Former name or former address if changed since last report.) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule
14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01 Other Events.
On May 13, 2010, Medco Health Solutions, Inc. (the “Company”) issued a press release, a copy of which is attached hereto as Exhibit 99.1, announcing that its Board of Directors has authorized a new $3 billion common stock repurchase program. Pursuant to this authorization, the Company may purchase shares from time to time in the open market or through privately negotiated transactions through May 17, 2012.
Item 9.01 Financial Statements and Exhibits.
Exhibit No. |
Description | |
99.1 |
Press Release dated May 13, 2010 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
MEDCO HEALTH SOLUTIONS, INC.
Date: May 13, 2010
By: /s/ Thomas M. Moriarty
Thomas M. Moriarty
General Counsel, Secretary and Senior Vice President,
Pharmaceutical Strategies and Solutions
EXHIBIT INDEX
Exhibit No. |
Description | |
99.1 |
Press Release dated May 13, 2010 |